Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes
暂无分享,去创建一个
J. Gribben | J. Fitzgibbon | V. Rajeeve | P. Cutillas | P. Casado | A. Parsons | C. Bödör | A. Rio-Machin | K. Rouault-Pierre | C. Heckman | D. Taussig | F. Miraki-Moud | F. Bewicke-Copley | Juho J Miettinen | S. Krizsán